Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR

BACKGROUND: Relapse remains the primary cause of death after hematopoietic cell transplantation (HCT) for acute leukemia. The ability to identify minimal/measurable residual disease (MRD) via the blood could identify patients earlier when immunologic interventions may be more successful. We evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanojevic, M., Grant, M., Vesely, S. K., Knoblach, S., Kanakry, C. G., Nazarian, J., Panditharatna, E., Panchapakesan, K., Gress, R. E., Holter-Chakrabarty, J., Williams, Kirsten M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556966/
https://www.ncbi.nlm.nih.gov/pubmed/36248870
http://dx.doi.org/10.3389/fimmu.2022.999298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556966/
https://www.ncbi.nlm.nih.gov/pubmed/36248870
http://dx.doi.org/10.3389/fimmu.2022.999298

Ejemplares similares